MYRIAD GENETICS INC (MYGN) 18.21 -0.2 (-1.09%)
18.21 -0.2 (-1.09%)
US62855J1043 - Common Stock - After market: 18.21 0 (0%)
| TTM (2022-6-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-6-30) | 2018 (2018-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -17.60M | -27.20M | -53.10M | 4.60M | 131.10M | |||
| Depreciation Amortization | 53.40M | 62.80M | 35.80M | 73.00M | 54.40M | |||
| Income Taxes - Deferred | -31.20M | -32.10M | 44.20M | 18.60M | -23.50M | |||
| Taxes Paid | 3.80M | -85.40M | 1.80M | 6.50M | 11.70M | |||
| OPERATING CASH FLOW | -146.00M | 18.20M | -73.70M | 83.70M | 115.90M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Other Investing Activity | 231.20M | 292.40M | 35.90M | -277.80M | -3.20M | |||
| INVESTING CASH FLOW | 211.80M | 274.40M | 28.00M | -286.40M | -11.60M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -106.40M | -226.40M | N/A | 225.00M | -90.00M | |||
| Stock Issued/Repurchased | 28.50M | 80.30M | -2.00M | -41.30M | 36.90M | |||
| Other Financing Activity | 0.00 | -4.50M | -100.00K | -1.40M | -41.90M | |||
| FINANCING CASH FLOW | -77.90M | -150.60M | -2.10M | 182.30M | -95.00M | |||
| Exchange Rate Effect | -1.10M | -600.00K | 1.10M | 2.70M | -800.00K | |||
| CHANGE IN CASH | -13.20M | 141.40M | -46.70M | -17.70M | 8.50M | |||
| CHANGE IN WORKING CAPITAL | -78.80M | 120.40M | -131.80M | -37.10M | -21.60M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -146.00M | 18.20M | -73.70M | 83.70M | 115.90M | |||
| Capital Expenditure | -19.40M | -18.00M | -7.90M | -8.60M | -8.40M | |||
| FREE CASH FLOW | -165.40M | 200.00K | -81.60M | 75.10M | 107.50M | |||
All data in USD